Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurotransmitter Agents”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Large-scale testing (Phase 3)Study completedNCT03396588
What this trial is testing

Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain

Who this might be right for
Neonatal Abstinence Syndrome
Henrietta Bada 120
Post-approval studies (Phase 4)Study completedNCT01728194
What this trial is testing

Emotional and Cognitive Control in Late-Onset Depression

Who this might be right for
Depression
Weill Medical College of Cornell University 121
Post-approval studies (Phase 4)Study completedNCT05657860
What this trial is testing

Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome

Who this might be right for
Prader-Willi SyndromeAggressionSelf-Injurious Behavior+18 more
Maimonides Medical Center 15
Early research (Phase 1)Study completedNCT03357796
What this trial is testing

Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®

Who this might be right for
Major Depressive Disorder
Luye Pharma Group Ltd. 20
Large-scale testing (Phase 3)Looking for participantsNCT06752759
What this trial is testing

Nebulized Ketamine for the Treatment of Major Depressive Disorder

Who this might be right for
Severe DepressionModerate DepressionKetamine+14 more
Theresa Jacob, PhD, MPH 40
Early research (Phase 1)Study completedNCT04922593
What this trial is testing

Relative Bioavailability of LY03010 Compared to Listed Drug

Who this might be right for
SchizophreniaPsychotic DisordersMood Disorders+9 more
Luye Pharma Group Ltd. 281
Not applicableUnknownNCT06204965
What this trial is testing

The Impact of Time-restricted Eating on the Outcomes Associated With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Joanna Bajerska 52
Testing effectiveness (Phase 2)Study completedNCT02634684
What this trial is testing

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

Who this might be right for
Schizophrenia
University of California, San Diego 82
Not applicableStudy completedNCT07079046
What this trial is testing

Efficacy of Satisens® in Reducing Emotional Eating

Who this might be right for
Emotional EatingOverweight or ObesityHormonal Changes+5 more
José Enrique de la Rubia Ortí, Ph 84
Early research (Phase 1)Study completedNCT02577250
What this trial is testing

Ketamine Infusions for PTSD and Treatment-Resistant Depression

Who this might be right for
Depressive Disorder, Treatment-ResistantStress Disorders, Post-Traumatic
Minneapolis Veterans Affairs Medical Center 20
Testing effectiveness (Phase 2)UnknownNCT04228653
What this trial is testing

Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions

Who this might be right for
Parkinson DiseaseMovement DisordersNeuro-Degenerative Disease+2 more
Renishaw 15
Not applicableStudy completedNCT01366196
What this trial is testing

Pregabalin for the Treatment of Pain After Posterior Spinal Fusions

Who this might be right for
Lumbar Spinal Fusions
Hospital for Special Surgery, New York 86
Testing effectiveness (Phase 2)Ended earlyNCT03250117
What this trial is testing

Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole

Who this might be right for
Parkinson Disease
Titan Pharmaceuticals 6
Testing effectiveness (Phase 2)Looking for participantsNCT06511908
What this trial is testing

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

Who this might be right for
SuicideDepressive Disorder, Treatment-ResistantKetamine+10 more
National Institute of Mental Health (NIMH) 50
Post-approval studies (Phase 4)Study completedNCT01049009
What this trial is testing

The Effect of Nebivolol on Endothelial Dysfunction in African Americans With Hypertension

Who this might be right for
High Blood Pressure
Emory University 91
Early research (Phase 1)Study completedNCT02045264
What this trial is testing

Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers

Who this might be right for
Hereditary Angioedema (HAE)
Shire 12
Large-scale testing (Phase 3)Active Not RecruitingNCT07122193
What this trial is testing

NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States

Who this might be right for
Neuromuscular AgentsPeripheral Nervous System AgentsPhysiological Effects of Drugs+7 more
Merz North America, Inc. 300
Testing effectiveness (Phase 2)Ended earlyNCT02483884
What this trial is testing

PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer

Who this might be right for
Prostate Cancer
Lantheus Biosciences Ltd. 30
Post-approval studies (Phase 4)Looking for participantsNCT05585125
What this trial is testing

A Preliminary Study for INFORMED

Who this might be right for
Heart FailureHeart Failure, DiastolicHeart Failure With Preserved Ejection Fraction+2 more
Weill Medical College of Cornell University 18
Early research (Phase 1)Study completedNCT01204723
What this trial is testing

Medications Development for the Treatment of Cannabis Related Disorders

Who this might be right for
Nicotine WithdrawalMarijuana DependenceCannabis Dependence+2 more
University of Virginia 63
Next Page